Advertisement
Screener

NeuroSense Therapeutics Ltd. (NRSN) Form 6-K: Report of foreign private issuer, 2023

NeuroSense Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-27: Form 6-K; Period of report 2023-12-27; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190761-6k_neurosense.htm.
  • 2023-12-21: Form 6-K; Period of report 2023-12-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190414-6k_neurosense.htm.
  • 2023-12-14: Form 6-K; Period of report 2023-12-14; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea190041-6k_neurosense.htm.
  • 2023-12-05: Form 6-K; Period of report 2023-12-05; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea189521-6k_neurosense.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-276-K2023-12-27REPORT OF FOREIGN PRIVATE ISSUERea190761-6k_neurosense.htm
2023-12-216-K2023-12-21REPORT OF FOREIGN PRIVATE ISSUERea190414-6k_neurosense.htm
2023-12-146-K2023-12-14REPORT OF FOREIGN PRIVATE ISSUERea190041-6k_neurosense.htm
2023-12-056-K2023-12-05REPORT OF FOREIGN PRIVATE ISSUERea189521-6k_neurosense.htm
2023-11-286-K2023-11-28REPORT OF FOREIGN PRIVATE ISSUERea189136-6k_neurosense.htm
2023-11-136-K2023-11-13REPORT OF FOREIGN PRIVATE ISSUERea188172-6k_neurosense.htm
2023-11-066-K2023-11-06REPORT OF FOREIGN PRIVATE ISSUERea187762-6k_neurosense.htm
2023-10-176-K2023-10-17REPORT OF FOREIGN PRIVATE ISSUERea186872-6k_neurosense.htm
2023-10-046-K2023-10-04REPORT OF FOREIGN PRIVATE ISSUERea186314-6k_neurosense.htm
2023-10-026-K2023-10-02REPORT OF FOREIGN PRIVATE ISSUERea186143-6k_neurosense.htm
2023-09-296-K2023-09-29REPORT OF FOREIGN PRIVATE ISSUERea185895-6k_neurosense.htm
2023-09-206-K2023-09-20REPORT OF FOREIGN PRIVATE ISSUERea185482-6k_neurosense.htm
2023-09-196-K2023-09-19REPORT OF FOREIGN PRIVATE ISSUERea185417-6k_neurosense.htm
2023-09-126-K2023-09-12REPORT OF FOREIGN PRIVATE ISSUERea185079-6k_neurosense.htm
2023-08-166-K2023-06-30REPORT OF FOREIGN PRIVATE ISSUERea183614-6k_neurosense.htm
2023-07-066-K2023-07-06REPORT OF FOREIGN PRIVATE ISSUERea181401-6k_neurosense.htm
2023-06-236-K2023-06-23REPORT OF FOREIGN PRIVATE ISSUERea180854-6k_neurosense.htm
2023-06-136-K2023-06-13REPORT OF FOREIGN PRIVATE ISSUERea180269-6k_neurosense.htm
2023-06-086-K2023-06-08REPORT OF FOREIGN PRIVATE ISSUERea179995-6k_neurosense.htm
2023-06-016-K2023-06-01REPORT OF FOREIGN PRIVATE ISSUERea179623-6k_neurosense.htm
2023-05-316-K2023-05-31REPORT OF FOREIGN PRIVATE ISSUERea179569-6k_neurosense.htm
2023-05-256-K2023-05-25REPORT OF FOREIGN PRIVATE ISSUERea179223-6k_neurosense.htm
2023-05-156-K2023-05-15REPORT OF FOREIGN PRIVATE ISSUERea178582-6k_neurosense.htm
2023-05-026-K2023-05-02REPORT OF FOREIGN PRIVATE ISSUERea177845-6k_neurosense.htm
2023-05-026-K2023-05-02REPORT OF FOREIGN PRIVATE ISSUERea177858-6k_neurosense.htm
2023-04-266-K2023-04-26REPORT OF FOREIGN PRIVATE ISSUERea177368-6k_neurosense.htm
2023-04-206-K2023-04-20REPORT OF FOREIGN PRIVATE ISSUERea177237-6k_neurosense.htm
2023-04-176-K2023-04-17FORM 6-Kea177060-6k_neurosense.htm
2023-04-176-K2023-04-17FORM 6-Kea177041-6k_neurosense.htm
2023-04-146-K2023-04-14FORM 6-Kea176908-6k_neurosense.htm
2023-03-206-K2023-03-20REPORT OF FOREIGN PRIVATE ISSUERea175484-6k_neurosense.htm
2023-02-136-K2023-02-13REPORT OF FOREIGN PRIVATE ISSUERea173305-6k_neurosense.htm
2023-02-096-K2023-02-09REPORT OF FOREIGN PRIVATE ISSUERea173072-6k_neurosense.htm
2023-02-086-K2023-02-08REPORT OF FOREIGN PRIVATE ISSUERea172965-6k_neurosense.htm
2023-02-066-K2023-02-06REPORT OF FOREIGN PRIVATE ISSUERea172785-6k_neurosense.htm
2023-01-196-K/A2022-06-30FORM 6-K/Aea171503-6ka_neurosense.htm
2023-01-196-K2023-01-19REPORT OF FOREIGN PRIVATE ISSUERea171911-6k_neurosense.htm